Keywords: Amylin. Eli Lilly, Novo Nordiwk, Bydureon, Victoza, Type 2 diabetes, Head-to-head trial

Head-to-head trial of diabetes drugs Victoza and Bydureon yields mixed results

Article | 08 November 2012

Print This

A direct, head-to-head comparison of two of the newer treatments available for type 2 diabetes yielded mixed results. It was sponsored ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in